Smart Money Alert

Concord Biotech Limited

DecreasedQuarterly

CONCORDBIOPharmaceuticalsMarket Cap₹14K Cr

Stake

2.99% → 2.95%

Government Pension Fund Global (Norway)

Foreign Investor

The move

Government Pension Fund Global (Norway) decreased its stake in Concord Biotech Limited from 2.99% to 2.95%, selling 36,910 shares.

About Concord Biotech Limited

Visit stock

An R&D-driven biopharma company engaged in manufacturing fermentation-based active pharmaceutical ingredients for immunosuppressants and oncology applications. Established in 1984, the company specializes in complex fermentation technology and serves domestic and international pharmaceutical markets with differentiated API solutions. Its focus on bioprocess innovation and vertical integration in fermentation-based manufacturing distinguishes it within the competitive global pharmaceutical ingredients landscape.

About Government Pension Fund Global (Norway)

Visit investor

Norway's sovereign wealth fund, managed by Norges Bank Investment Management. World's largest SWF with over USD 2 trillion in assets, invested across 8,700+ companies globally including Indian equities.

Get the next move the moment it happens.

Follow Government Pension Fund Global (Norway) and Concord Biotech Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Concord Biotech Limited shareholders Government Pension Fund Global (Norway)'s portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Concord Biotech Limited

DSP Mutual FundNew position

DSP Mutual Fund bought 12,88,114 shares of Concord Biotech Limited for ₹180.86 Cr at ₹1404.10 apiece in a bulk deal.

31 Aug 2026

Max Life InsuranceDecreased

Max Life Insurance decreased its stake in Concord Biotech Limited from 1.52% to 1.34%, selling 187,698 shares. The value of the shares sold is ₹25.2 Cr at a share price of ₹1342.80.